Daehan Nupharm Co.,Ltd. (KOSDAQ:054670)

South Korea flag South Korea · Delayed Price · Currency is KRW
7,260.00
+10.00 (0.14%)
At close: Mar 27, 2026
Market Cap101.90B +2.7%
Revenue (ttm)202.40B -0.1%
Net Income15.26B +14.6%
EPSn/a +14.6%
Shares Out14.04M
PE Ratio6.68
Forward PEn/a
Dividend100.00 (1.38%)
Ex-Dividend DateDec 29, 2025
Volume134,369
Average Volume406,306
Open7,250.00
Previous Close7,250.00
Day's Range7,050.00 - 7,340.00
52-Week Range6,260.00 - 8,810.00
Beta0.38
RSI61.65
Earnings DateDec 2, 2025

About Daehan Nupharm

Daehan Nupharm Co.,Ltd. manufactures and sells pharmaceuticals and veterinary products in South Korea and internationally. It offers pharmaceuticals drugs for cardiovascular, endocrine system, neuropsychiatric, gastrointestinal, respiratory system, antipyretic, analgesic, anti-inflammatory, anti-infective, musculoskeletal, osteoporosis, anti-cancer, urogenital system, antifungal, antiviral, hormones, dermatologic, central nervous system, anticonvulsive, amino acid, anesthetic, antiobesity, and others; vitamins; and inorganic products. The compa... [Read more]

Industry Pharmaceutical Preparations
Founded 1984
Employees 228
Stock Exchange KOSDAQ
Ticker Symbol 054670
Full Company Profile

Financial Performance

In 2024, Daehan Nupharm's revenue was 202.19 billion, a decrease of -1.00% compared to the previous year's 204.22 billion. Earnings were 15.47 billion, an increase of 23.33%.

Financial Statements